Demonstrates effective detection of APE1 activity in cancer cells, suggesting a novel diagnostic tool.
A label-free turn-on fluorescent biosensor is developed for APE1 activity detection based on APE1-gated release of poly-T strands from a constrained DNA duplex, which competitively displaces Ag⁺ from N-CQDs, recovering fluorescence. The sensor achieves a detection limit of 0.02 U mL⁻¹, excellent selectivity, and one-step operation. It successfully detects APE1 in serum (recoveries 92-108%) and in cancer cell lysates (MCF-7, MDA-MB-231, HeLa, HepG2), with a threshold as low as 192 cells, and distinguishes cancer cells from normal cells. This simple, robust platform holds promise for DNA repair research, cancer diagnostics, and inhibitor screening.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: